Agilent Life Sciences' Q2 Revenues Rise 12 Percent on Strong Asian Sales

Company officials attributed the spike in Life Sciences sales, which include receipts from the firm's microarray business, to double-digit demand in Asian markets.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.